Literature DB >> 18076550

Hepatosplenomegaly in Kenyan schoolchildren: exacerbation by concurrent chronic exposure to malaria and Schistosoma mansoni infection.

Shona Wilson1, Birgitte J Vennervald, Hilda Kadzo, Edmund Ireri, Clifford Amaganga, Mark Booth, H Curtis Kariuki, Joseph K Mwatha, Gachuhi Kimani, John H Ouma, Eric Muchiri, David W Dunne.   

Abstract

OBJECTIVES: Chronic exposure to malaria exacerbates Schistosoma mansoni-associated hepatosplenomegaly in school-aged children. However, residual hepatosplenomegaly after treatment of S. mansoni with concurrent mollusciciding suggests malaria could be an underlying cause of hepatosplenomegaly. We investigated the role of chronic malaria in childhood hepatosplenomegaly in the presence and absence of concurrent S. mansoni infection.
METHODS: Cross-sectional study of children in an study area where transmission of S. mansoni, but not malaria, is restricted to the eastern end. Clinical and ultrasound examinations were conducted, and parasitological and serological tests used to determine S. mansoni infection intensities and comparative exposure levels to malaria.
RESULTS: Chronic exposure to malaria, as determined by Pfs-IgG3 levels, was associated with hepatosplenomegaly even in the absence of S. mansoni infection. Children infected with S. mansoni mostly had light to moderate infection intensities but greater enlargement of the liver and spleen than children who did not have schistosomiasis, and for the left liver lobe this was S. mansoni infection intensity dependent.
CONCLUSIONS: Children chronically exposed to malaria but without S. mansoni infection can have hepatosplenomegaly, which even light S. mansoni infections can exacerbate in an intensity-dependent manner. Thus, concurrent chronic exposure to S. mansoni and Plasmodium falciparum can have an additive or synergistic effect on childhood morbidity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18076550     DOI: 10.1111/j.1365-3156.2007.01950.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  25 in total

1.  Patent filarial infection modulates malaria-specific type 1 cytokine responses in an IL-10-dependent manner in a filaria/malaria-coinfected population.

Authors:  Simon Metenou; Benoit Dembélé; Siaka Konate; Housseini Dolo; Siaka Y Coulibaly; Yaya I Coulibaly; Abdallah A Diallo; Lamine Soumaoro; Michel E Coulibaly; Dramane Sanogo; Salif S Doumbia; Marissa Wagner; Sekou F Traoré; Amy Klion; Siddhartha Mahanty; Thomas B Nutman
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

Review 2.  The WHO ultrasonography protocol for assessing hepatic morbidity due to Schistosoma mansoni. Acceptance and evolution over 12 years.

Authors:  Tarik el Scheich; Martha C Holtfreter; Hendrik Ekamp; Daman D Singh; Rodrigo Mota; Christoph Hatz; Joachim Richter
Journal:  Parasitol Res       Date:  2014-09-27       Impact factor: 2.289

3.  Coinfection with Plasmodium falciparum and Schistosoma haematobium: additional evidence of the protective effect of Schistosomiasis on malaria in Senegalese children.

Authors:  Magali Lemaitre; Laurence Watier; Valérie Briand; André Garcia; Jean Yves Le Hesran; Michel Cot
Journal:  Am J Trop Med Hyg       Date:  2013-12-09       Impact factor: 2.345

4.  Hepatosplenomegaly is associated with low regulatory and Th2 responses to schistosome antigens in childhood schistosomiasis and malaria coinfection.

Authors:  Shona Wilson; Frances M Jones; Joseph K Mwatha; Gachuhi Kimani; Mark Booth; H Curtis Kariuki; Birgitte J Vennervald; John H Ouma; Eric Muchiri; David W Dunne
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

5.  Short report: Childhood coinfections with Plasmodium falciparum and Schistosoma mansoni result in lower percentages of activated T cells and T regulatory memory cells than schistosomiasis only.

Authors:  Erick M O Muok; Erick M O Mouk; Pauline N M Mwinzi; Carla L Black; Jennifer M Carter; Zipporah W Ng'ang'a; Michael M Gicheru; W Evan Secor; Diana M S Karanja; Daniel G Colley
Journal:  Am J Trop Med Hyg       Date:  2009-03       Impact factor: 2.345

6.  Effect of Brugia pahangi co-infection with Plasmodium berghei ANKA in gerbils (Meriones unguiculatus).

Authors:  Olawale Quazim Junaid; Indra Vythilingam; Loke Tim Khaw; Sinnadurai Sivanandam; Rohela Mahmud
Journal:  Parasitol Res       Date:  2020-03-16       Impact factor: 2.289

Review 7.  Review: analysis of parasite and other skewed counts.

Authors:  Neal Alexander
Journal:  Trop Med Int Health       Date:  2012-06       Impact factor: 2.622

Review 8.  Th2 responses in schistosomiasis.

Authors:  Keke Fairfax; Marcia Nascimento; Stanley Ching-Cheng Huang; Bart Everts; Edward J Pearce
Journal:  Semin Immunopathol       Date:  2012-11-09       Impact factor: 9.623

9.  Health implications of chronic hepatosplenomegaly in Kenyan school-aged children chronically exposed to malarial infections and Schistosoma mansoni.

Authors:  Shona Wilson; Birgitte J Vennervald; Hilda Kadzo; Edmund Ireri; Clifford Amaganga; Mark Booth; H Curtis Kariuki; Joseph K Mwatha; Gachuhi Kimani; John H Ouma; Eric Muchiri; David W Dunne
Journal:  Trans R Soc Trop Med Hyg       Date:  2009-10-08       Impact factor: 2.184

10.  Hepatosplenomegaly associated with chronic malaria exposure: evidence for a pro-inflammatory mechanism exacerbated by schistosomiasis.

Authors:  S Wilson; F M Jones; J K Mwatha; G Kimani; M Booth; H C Kariuki; B J Vennervald; J H Ouma; E Muchiri; D W Dunne
Journal:  Parasite Immunol       Date:  2009-02       Impact factor: 2.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.